Literature DB >> 26061888

Comparison of statistical inferences from the DerSimonian-Laird and alternative random-effects model meta-analyses - an empirical assessment of 920 Cochrane primary outcome meta-analyses.

Kristian Thorlund1,2, Jørn Wetterslev3, Tahany Awad4, Lehana Thabane3,5, Christian Gluud6.   

Abstract

In random-effects model meta-analysis, the conventional DerSimonian-Laird (DL) estimator typically underestimates the between-trial variance. Alternative variance estimators have been proposed to address this bias. This study aims to empirically compare statistical inferences from random-effects model meta-analyses on the basis of the DL estimator and four alternative estimators, as well as distributional assumptions (normal distribution and t-distribution) about the pooled intervention effect. We evaluated the discrepancies of p-values, 95% confidence intervals (CIs) in statistically significant meta-analyses, and the degree (percentage) of statistical heterogeneity (e.g. I(2)) across 920 Cochrane primary outcome meta-analyses. In total, 414 of the 920 meta-analyses were statistically significant with the DL meta-analysis, and 506 were not. Compared with the DL estimator, the four alternative estimators yielded p-values and CIs that could be interpreted as discordant in up to 11.6% or 6% of the included meta-analyses pending whether a normal distribution or a t-distribution of the intervention effect estimates were assumed. Large discrepancies were observed for the measures of degree of heterogeneity when comparing DL with each of the four alternative estimators. Estimating the degree (percentage) of heterogeneity on the basis of less biased between-trial variance estimators seems preferable to current practice. Disclosing inferential sensitivity of p-values and CIs may also be necessary when borderline significant results have substantial impact on the conclusion.
Copyright © 2012 John Wiley & Sons, Ltd. Copyright © 2012 John Wiley & Sons, Ltd.

Keywords:  between‐trial variance estimator; heterogeneity; inferences; random‐effects meta‐analysis

Year:  2012        PMID: 26061888     DOI: 10.1002/jrsm.53

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  18 in total

1.  Efficient network meta-analysis: a confidence distribution approach.

Authors:  Guang Yang; Dungang Liu; Regina Y Liu; Minge Xie; David C Hoaglin
Journal:  Stat Methodol       Date:  2014-09-01

Review 2.  Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.

Authors:  Chryssa Pourzitaki; Georgia Tsaousi; Eirini Apostolidou; Konstantinos Karakoulas; Dimitrios Kouvelas; Ekaterini Amaniti
Journal:  Br J Clin Pharmacol       Date:  2016-04-24       Impact factor: 4.335

3.  High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Lifang Huang; Lang Wang; Jianghong Tan; Hong Liu; Yanhui Ni
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

4.  Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis.

Authors:  Zhipeng Shi; Wen Yang; Hao Tang; Xiuhong Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

5.  Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study.

Authors:  Areti Angeliki Veroniki; Dimitris Mavridis; Julian P T Higgins; Georgia Salanti
Journal:  BMC Med Res Methodol       Date:  2014-09-19       Impact factor: 4.615

6.  How does under-reporting of negative and inconclusive results affect the false-positive rate in meta-analysis? A simulation study.

Authors:  Michal Kicinski
Journal:  BMJ Open       Date:  2014-08-28       Impact factor: 2.692

7.  Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses.

Authors:  Kristian Thorlund; Georgina Imberger; Bradley C Johnston; Michael Walsh; Tahany Awad; Lehana Thabane; Christian Gluud; P J Devereaux; Jørn Wetterslev
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

8.  Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?

Authors:  Kristian Thorlund; Lehana Thabane; Edward J Mills
Journal:  BMC Med Res Methodol       Date:  2013-01-11       Impact factor: 4.615

9.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.

Authors:  Joanna IntHout; John P A Ioannidis; George F Borm
Journal:  BMC Med Res Methodol       Date:  2014-02-18       Impact factor: 4.615

10.  Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group.

Authors:  Joanne E McKenzie; Georgia Salanti; Steff C Lewis; Douglas G Altman
Journal:  Syst Rev       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.